Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goetz

Showing results (571-580 of 754) with videos related to

Pageof 76
Sort By:
Clinical Neuropharmacology|August 1, 1991
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter studyW C Koller, G A Block, J E Ahlskog, et al.
Progress in Brain Research|January 1, 1990
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factorP M Carvey, A McRae, L R Ptak, et al.
EMBO Reports|November 16, 2023
Blood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesisBenjamin Mary, Nandini Asokan, Katerina Jerabkova-Roda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseKlaus Seppi, Daniel Weintraub, Miguel Coelho, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2018
Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effectMatej Skorvanek, Jennifer G Goldman, Marjan Jahanshahi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2017
Global scales for cognitive screening in Parkinson's disease: Critique and recommendationsMatej Skorvanek, Jennifer G Goldman, Marjan Jahanshahi, et al.
Thrombosis and Haemostasis|August 7, 2015
Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activityEric Maurer, Mathieu Schaff, Nicolas Receveur, et al.
Pharmaceutical Medicine|May 30, 2026
Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease ProgressionEdmund Ben-Ami, Eitan Raveh, Eran Harpaz, et al.
Frontiers in Neurology|October 3, 2022
Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approachMichelle H S Tosin, Glenn T Stebbins, Christopher G Goetz, et al.
Cancer Cell|December 15, 2020
Visualizing CancerMatthew Krummel, Kenneth Hu, Elisabeth G E de Vries, et al.
Pageof 76

Showing results (571-580 of 754) with videos related to

Sort By:
Pageof 76
Clinical Neuropharmacology|August 1, 1991
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter studyW C Koller, G A Block, J E Ahlskog, et al.
Progress in Brain Research|January 1, 1990
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factorP M Carvey, A McRae, L R Ptak, et al.
EMBO Reports|November 16, 2023
Blood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesisBenjamin Mary, Nandini Asokan, Katerina Jerabkova-Roda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 25, 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseKlaus Seppi, Daniel Weintraub, Miguel Coelho, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2018
Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effectMatej Skorvanek, Jennifer G Goldman, Marjan Jahanshahi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2017
Global scales for cognitive screening in Parkinson's disease: Critique and recommendationsMatej Skorvanek, Jennifer G Goldman, Marjan Jahanshahi, et al.
Thrombosis and Haemostasis|August 7, 2015
Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activityEric Maurer, Mathieu Schaff, Nicolas Receveur, et al.
Pharmaceutical Medicine|May 30, 2026
Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease ProgressionEdmund Ben-Ami, Eitan Raveh, Eran Harpaz, et al.
Frontiers in Neurology|October 3, 2022
Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approachMichelle H S Tosin, Glenn T Stebbins, Christopher G Goetz, et al.
Cancer Cell|December 15, 2020
Visualizing CancerMatthew Krummel, Kenneth Hu, Elisabeth G E de Vries, et al.
Pageof 76